Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest UpdateTicker Report • 21 days ago
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB Get Free Report) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 4,600...
Share to Feed
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB Get Free Report) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Anebulo Pharmaceuticals, Inc. (ANEB) has disclosed a new risk, in the Debt & Financing category. Anebulo Pharmaceuticals, Inc. has undertaken a sig...
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse...